Skip to main content
KRRO
NASDAQ Life Sciences

Korro Bio获得8,500万美元超额私募资金

feedReported by Dow Jones Newswires
Sentiment info
Neutral
Importance info
9
Price
$11.18
Mkt Cap
$105.285M
52W Low
$5.204
52W High
$55.89
Market data snapshot near publication time

summarizeSummary

Korro Bio宣布了一项总计8,500万美元的超额私募。这是一项高度重要的资本筹集，代表了公司当前市值的相当大一部分。虽然“超额认购”性质表明了投资者的强烈信心，并为公司的运营和管道开发提供了大量资金，但也意味着现有股东将面临相当大的股权稀释。交易者将会权衡加强的资产负债表和延长的资本跑道带来的长期利益与股价立即受到的稀释影响。对于一家临床阶段生物技术公司来说，这笔资本注入对于其持续的研究和开发工作至关重要。

在该公告发布时，KRRO的交易价格为$11.18，交易所为NASDAQ，所属行业为Life Sciences，市值约为$1.1亿。 52周交易区间为$5.20至$55.89。 这则新闻被评估为中性市场情绪，重要性评分为9/10。 来源：Dow Jones Newswires。

show_chartPrice Chart

Share this article

Copied!

feed KRRO - Latest Insights

KRRO
Apr 16, 2026, 7:00 AM EDT
Filing Type: DEF 14A
Importance Score:
9
Korro Bio Discloses Highly Dilutive $85M PIPE Financing at Deep Discount, Executive Departures
Sentiment: Negative
View Wiseek Article
KRRO
Mar 20, 2026, 5:03 PM EDT
Filing Type: 424B5
Importance Score:
7
Prospectus filed for resale of 7.65M shares by private placement investors
Sentiment: Negative
View Wiseek Article
KRRO
Mar 13, 2026, 5:05 PM EDT
Filing Type: S-3
Importance Score:
8
Korro Bio Registers $88.7M in Shares for Resale by Private Placement Investors
Sentiment: Negative
View Wiseek Article
KRRO
Mar 12, 2026, 7:32 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Major Investor NEA 17 Increases Stake in Korro Bio with $5M Private Placement Purchase
Sentiment: Positive
View Wiseek Article
KRRO
Mar 12, 2026, 4:12 PM EDT
Filing Type: 10-K
Importance Score:
8
Korro Bio Details Clinical Program Termination, Workforce Reductions, and $90.1M Capital Raise in Annual Report
Sentiment: Neutral
View Wiseek Article
KRRO
Mar 12, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
9
Korro Bio Secures $85M Financing, Extends Runway to 2028, and Nominates New Clinical Candidate
Sentiment: Neutral
View Wiseek Article
KRRO
Mar 12, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
7
Korro Bio Nominates KRRO-121 for Clinical Development in Hyperammonemia, Updates Pipeline
Sentiment: Positive
View Wiseek Article
KRRO
Mar 09, 2026, 7:35 AM EDT
Filing Type: 8-K
Importance Score:
9
Korro Bio Secures $85M in Oversubscribed Private Placement, Extending Cash Runway into H2 2028
Sentiment: Positive
View Wiseek Article
KRRO
Mar 09, 2026, 7:31 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Korro Bio Secures $85M in Oversubscribed Private Placement
Sentiment: Neutral
View Wiseek Article
KRRO
Jan 27, 2026, 9:15 AM EST
Filing Type: 8-K
Importance Score:
8
Korro Bio Highlights "Blockbuster Potential" of KRRO-121 for Ammonia Control at Analyst Day
Sentiment: Positive
View Wiseek Article